October 24, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
Company
News Sectors
Automotive
Communications
Consumers
CSR
Electronics
Energy
Environment
Financial
Health & Med
Industrial
IT & Internet
Materials
Real Estate
Science & Research
Telecoms
Trade
Transportation
Departments
Annual Reports
Companies
News Alerts
News Search
Photo Gallery
Company Login
Japan Corporate News Network
About JCN
Privacy Policy
RSS  
Terms of Use
 
 
News Search

The results of your word search

Headline News

Eisai Launches Programs to Help Eliminate Lymphatic Filariasis By 2020 (Jan 31, 2012)

Eisai and Apollo Hospitals, HelpAge India to Improve Access to Medicines in India (Jan 18, 2011)

Eisai's New Sales Subsidiary in Canada (May 11, 2010)

Eisai to Sell Catheter Subsidiary to Terumo (June 19, 2008)

Takeda, Eisai Log Recurring Profit Falls in FY '07 (May 14, 2008)

Eisai Launches Sales Support Firm for Pharm. Machines in China (May 7, 2008)

M's Science and Eisai Sign Option Agreement for Sigma Agonist SA4503 (Mar 12, 2008)

Eisai Aiming to Achieve 1.5-T.-Yen Sales by FY 2016 (Mar 4, 2008)

Eisai to Buy Out U.S. Drug Maker MGI Pharma (Dec 10, 2007)

Eisai to Sell Kissei's Insulin Secretagogue in China (Sept 28, 2007)

more...
Press Release News

U.S. FDA Accepts sNDA For Antiepileptic Agent Fycompa as Adjunctive Treatment of Primary Generalized Tonic-Clonic Seizures (Oct 21, 2014)

U.S. FDA Grants Priority Review Status to NDA for Anticancer Agent Lenvatinib (Oct 15, 2014)

U.S. FDA Accepts Eisai's sNDA for BANZEL (Rufinamide) as Adjunctive Treatment in Pediatric Patients With Lennox-Gastaut Syndrome (Oct 15, 2014)

U.S. FDA Approves Antiemetic Agent Akynzeo For Prevention Of Chemotherapy-Induced Nausea and Vomiting (CINV) (Oct 14, 2014)

Eisai Launches Anti-Cancer Agent Halaven in Australia (Oct 1, 2014)

Phase III Trial of Aricept in Patients with Severe Alzheimer's Disease in China Meets Primary Endpoint (Sept 30, 2014)

Aricept Approved In Japan As Treatment For Dementia With Lewy Bodies (Sept 19, 2014)

Plasmacluster Ion Technology Reduced Airway Inflammation in Pediatric Patients with Mild to Moderate Atopic Asthma (Sept 18, 2014)

Eisai to Present Latest Clinical Data on Halaven(R) (Eribulin) and Lenvatinib at 39th ESMO Congress (Sept 17, 2014)

Eisai Enters Two Joint Research Agreements to Develop New Antimalarial Medicines (Sept 16, 2014)

more...
 
CSR Report Download
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)